"Treatment-resistant depression can be very complicated, especially for patients who do not respond to oral antidepressants ...

Johnson & Johnson JNJ announced that the FDA has approved its supplemental new drug application (sNDA), seeking approval for ...

Scientists in China have demonstrated a new kind of antidepressant could ... are hard to draw conclusions from. In 2022, the antidepressant drug sertraline (another seratonin re-uptake inhibitor ...

Johnson & Johnson (NYSE: JNJ) announced today the U.S. Food and Drug Administration (FDA) approval of a supplemental New Drug Application (sNDA) for SPRAVATO® (esketamine) CIII nasal spray, making ...

Federal regulators have just given the green light to a second new kind of antidepressant this month, after decades of little progress combating the disease. The US Food and Drug Administration on ...

The FDA says esketamine, an antidepressant derived from the anesthetic and party drug ketamine, can now be prescribed on its ...

Antidepressants known as selective serotonin reuptake inhibitors, or SSRIs have been the first line of treatment for mood disorders and anxiety for the last three decades. These medicines mainly ...

Purpose: The association of antipsychotic and antidepressant drugs with Q-T ... hepatic insufficiency, and stimulant drug abuse contribute to the risk for developing these arrhythmias, as do ...